Summary
- Current Price
- As of today, TSHA price is $5.95, down -0.67% on
- Current Price All-Time High
- TSHA price is currently -82.16% below its historical high of $33.35 set on
- Market Cap
- TSHA current market cap is $2B, up +141.79% over the past 365 days
- Revenue
- TSHA current annual revenue is $9.77M, up +17.28% year-over-year
- Next Earnings
- The next earnings release for TSHA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Taysha Gene Therapies, Inc. |
| Ticker | NASDAQ: TSHA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tayshagtx.com |
| Employees | 73 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $5.95 | |
| Price, 1D Change | -0.67% | |
| $2B | ||
| - | ||
| - | ||
| 1.87 | ||
| $9.77M | ||
| Revenue, 1Y Change | +17.28% | |
| -$0.34 | ||
| EPS, 1Y Change | +4.51% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.34 | ||
| EPS Estimate | -$0.45 | N/A |
| EPS Est. Change | -31.27% | N/A |
| $9.77M | ||
| Revenue Estimate | $500.00K | N/A |
| Revenue Est. Change | -94.88% | N/A |
| Current Price | $5.95 | |
| Price Target | $12.50 | - |
| Price Tgt. Change | +110.08% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.31 | -$0.36 | -15.16% | |
| -$0.34 | -$0.34 | -1.25% | |
| -$0.45 | N/A | -31.27% | |
| -$0.47 | N/A | -36.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.25M | $8.33M | +1.06% | |
| $6.30M | $9.77M | +55.11% | |
| $500.00K | N/A | -94.88% | |
| $23.24M | N/A | +137.82% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $5.95 | |
| $5.32 | ||
| $6.07 | ||
| $5.25 | ||
| $6.03 | ||
| $0.07 | ||
| 1.87 | ||
| $0.40 | ||
| 47.39 | ||
| 70.75% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $9.77M | ||
| -$0.34 | ||
| $0.00 | ||
| 88.28% | ||
| -$110.50M | ||
| -1,130.65% | ||
| -$109.00M | ||
| -1,115.27% | ||
| -$109.35M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.28 | ||
| 12.23 | ||
| 12.23 | ||
| - | ||
| - | ||
| 2.86 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 259.50 | ||
| 9.15 | ||
| -13.17 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $246.94M | ||
| $320.22M | ||
| $483.73M | ||
| $324.65M | ||
| $236.79M | ||
| $26.55M | ||
| $68.28M | ||
| $2.24M | ||
| $6.28M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $118.77M | ||
| $110.50M | ||
| $1.15M | ||
| $0.00 | ||
| $1.15M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$93.09M | ||
| -$604.00K | ||
| $274.59M | ||
| $738.00K | ||
| -$93.83M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Goldman Sachs | → | |
| Citizens | → | |
| Needham | → | |
| Baird | → | |
| Citizens | → | |
| B of A Securities | → | |
| BMO Capital | → | |
| Needham | → | |
| Canaccord Genuity | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with TSHA
FAQ
- What is the ticker symbol for Taysha Gene Therapies, Inc.?
- The ticker symbol for Taysha Gene Therapies, Inc. is NASDAQ:TSHA
- Does Taysha Gene Therapies, Inc. pay dividends?
- No, Taysha Gene Therapies, Inc. does not pay dividends
- What sector is Taysha Gene Therapies, Inc. in?
- Taysha Gene Therapies, Inc. is in the Healthcare sector
- What industry is Taysha Gene Therapies, Inc. in?
- Taysha Gene Therapies, Inc. is in the Biotechnology industry
- What country is Taysha Gene Therapies, Inc. based in?
- Taysha Gene Therapies, Inc. is headquartered in United States
- When did Taysha Gene Therapies, Inc. go public?
- Taysha Gene Therapies, Inc. initial public offering (IPO) was on September 24, 2020
- Is Taysha Gene Therapies, Inc. in the S&P 500?
- No, Taysha Gene Therapies, Inc. is not included in the S&P 500 index
- Is Taysha Gene Therapies, Inc. in the NASDAQ 100?
- No, Taysha Gene Therapies, Inc. is not included in the NASDAQ 100 index
- Is Taysha Gene Therapies, Inc. in the Dow Jones?
- No, Taysha Gene Therapies, Inc. is not included in the Dow Jones index
- When was Taysha Gene Therapies, Inc. last earnings report?
- Taysha Gene Therapies, Inc.'s most recent earnings report was on August 11, 2026
- When does Taysha Gene Therapies, Inc. report earnings?
- The next expected earnings date for Taysha Gene Therapies, Inc. is November 4, 2026
Data Sources & References
- TSHA Official Website www.tayshagtx.com
- TSHA Profile on Yahoo Finance finance.yahoo.com/quote/TSHA
- TSHA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tsha